About Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome
Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome is a rare disease catalogued by Orphanet (ORPHA:447893). It is associated with the POLR3A gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome trials.
Search ClinicalTrials.gov for "Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome" or filter by Orphanet code ORPHA:447893 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome. Updated daily.